149 related articles for article (PubMed ID: 38151762)
1. Influence of postdiagnostic aspirin use on clinical outcomes of women with breast cancer: a meta-analysis.
Wu C; Hu M; Zhang S; Zhang J; Shen L; Shen X
Women Health; 2024 Feb; 64(2):94-108. PubMed ID: 38151762
[TBL] [Abstract][Full Text] [Related]
2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
3. Association between aspirin use and mortality in breast cancer patients: a meta-analysis of observational studies.
Zhong S; Zhang X; Chen L; Ma T; Tang J; Zhao J
Breast Cancer Res Treat; 2015 Feb; 150(1):199-207. PubMed ID: 25677744
[TBL] [Abstract][Full Text] [Related]
4. Oncoplastic breast-conserving surgery for women with primary breast cancer.
Nanda A; Hu J; Hodgkinson S; Ali S; Rainsbury R; Roy PG
Cochrane Database Syst Rev; 2021 Oct; 10(10):CD013658. PubMed ID: 34713449
[TBL] [Abstract][Full Text] [Related]
5. Aspirin might reduce the incidence of breast cancer: An updated meta-analysis of 38 observational studies.
Cao Y; Tan A
Medicine (Baltimore); 2020 Sep; 99(38):e21917. PubMed ID: 32957311
[TBL] [Abstract][Full Text] [Related]
6. Aspirin and nonsteroidal anti-inflammatory drugs after but not before diagnosis are associated with improved breast cancer survival: a meta-analysis.
Huang XZ; Gao P; Sun JX; Song YX; Tsai CC; Liu J; Chen XW; Chen P; Xu HM; Wang ZN
Cancer Causes Control; 2015 Apr; 26(4):589-600. PubMed ID: 25701248
[TBL] [Abstract][Full Text] [Related]
7. Risk-reducing medications for primary breast cancer: a network meta-analysis.
Mocellin S; Goodwin A; Pasquali S
Cochrane Database Syst Rev; 2019 Apr; 4(4):CD012191. PubMed ID: 31032883
[TBL] [Abstract][Full Text] [Related]
8. Recent prediagnostic aspirin use, lymph node involvement, and 5-year mortality in women with stage I-III breast cancer: a nationwide population-based cohort study.
Barron TI; Flahavan EM; Sharp L; Bennett K; Visvanathan K
Cancer Res; 2014 Aug; 74(15):4065-77. PubMed ID: 25085874
[TBL] [Abstract][Full Text] [Related]
9. Effect of aspirin use on survival benefits of breast cancer patients: A meta-analysis.
Liu J; Zheng F; Yang M; Wu X; Liu A
Medicine (Baltimore); 2021 Aug; 100(33):e26870. PubMed ID: 34414938
[TBL] [Abstract][Full Text] [Related]
10. Mammography in combination with breast ultrasonography versus mammography for breast cancer screening in women at average risk.
Glechner A; Wagner G; Mitus JW; Teufer B; Klerings I; Böck N; Grillich L; Berzaczy D; Helbich TH; Gartlehner G
Cochrane Database Syst Rev; 2023 Mar; 3(3):CD009632. PubMed ID: 36999589
[TBL] [Abstract][Full Text] [Related]
11. Aspirin use and risk of breast cancer: systematic review and meta-analysis of observational studies.
Zhong S; Chen L; Zhang X; Yu D; Tang J; Zhao J
Cancer Epidemiol Biomarkers Prev; 2015 Nov; 24(11):1645-55. PubMed ID: 26315555
[TBL] [Abstract][Full Text] [Related]
12. Risk-reducing bilateral salpingo-oophorectomy in women with BRCA1 or BRCA2 mutations.
Eleje GU; Eke AC; Ezebialu IU; Ikechebelu JI; Ugwu EO; Okonkwo OO
Cochrane Database Syst Rev; 2018 Aug; 8(8):CD012464. PubMed ID: 30141832
[TBL] [Abstract][Full Text] [Related]
13. Safety of fertility preservation techniques before and after anticancer treatments in young women with breast cancer: a systematic review and meta-analysis.
Arecco L; Blondeaux E; Bruzzone M; Ceppi M; Latocca MM; Marrocco C; Boutros A; Spagnolo F; Razeti MG; Favero D; Spinaci S; Condorelli M; Massarotti C; Goldrat O; Del Mastro L; Demeestere I; Lambertini M
Hum Reprod; 2022 May; 37(5):954-968. PubMed ID: 35220429
[TBL] [Abstract][Full Text] [Related]
14. Aspirin Exposure and Mortality Risk among Prostate Cancer Patients: A Systematic Review and Meta-Analysis.
Fan LL; Xie CP; Wu YM; Gu XJ; Chen YH; Wang YJ
Biomed Res Int; 2019; 2019():9379602. PubMed ID: 31073532
[TBL] [Abstract][Full Text] [Related]
15. Aspirin Use and Risk of Breast Cancer: A Meta-analysis of Observational Studies from 1989 to 2019.
Ma S; Guo C; Sun C; Han T; Zhang H; Qu G; Jiang Y; Zhou Q; Sun Y
Clin Breast Cancer; 2021 Dec; 21(6):552-565. PubMed ID: 33741292
[TBL] [Abstract][Full Text] [Related]
16. Aspirin for prophylactic use in the primary prevention of cardiovascular disease and cancer: a systematic review and overview of reviews.
Sutcliffe P; Connock M; Gurung T; Freeman K; Johnson S; Kandala NB; Grove A; Gurung B; Morrow S; Clarke A
Health Technol Assess; 2013 Sep; 17(43):1-253. PubMed ID: 24074752
[TBL] [Abstract][Full Text] [Related]
17. Aspirin Use and Survival Among Patients With Breast Cancer: A Systematic Review and Meta-Analysis.
Baker A; Kartsonaki C
Oncologist; 2024 Jan; 29(1):e1-e14. PubMed ID: 37358878
[TBL] [Abstract][Full Text] [Related]
18. De Novo Post-Diagnosis Aspirin Use and Mortality in Women with Stage I-III Breast Cancer.
Barron TI; Murphy LM; Brown C; Bennett K; Visvanathan K; Sharp L
Cancer Epidemiol Biomarkers Prev; 2015 Jun; 24(6):898-904. PubMed ID: 25791705
[TBL] [Abstract][Full Text] [Related]
19. Selenium for preventing cancer.
Vinceti M; Filippini T; Del Giovane C; Dennert G; Zwahlen M; Brinkman M; Zeegers MP; Horneber M; D'Amico R; Crespi CM
Cochrane Database Syst Rev; 2018 Jan; 1(1):CD005195. PubMed ID: 29376219
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
